Advertisement

Dopamine Agonists/Antagonists in the Treatment of Gastrointestinal Diseases

  • Herbert S. OrmsbeeIII
Part of the New Horizons in Therapeutics book series (NHTH)

Abstract

The smooth muscle relaxant effects of dopamine observed in vascular tissue also extend to the smooth muscle of the gastrointestinal tract. For example, dopamine is known to relax the lower esophageal sphincter and has been suggested as a mediator of receptive relaxation of the stomach (Valenzuela, 1976). In contrast, contraction of GI muscle to dopamine has been reported from several locations in the GI tract in at least two species (Lanfranchi et al., 1978a; Anuras, 1981). Besides these smooth muscle effects, dopamine has a number of other interesting effects on GI function. Dopamine reduces pentagastrin-stimulated acid secretion in man, and it has been implicated in animal experiments to be involved in the pathogenesis of duodenal ulcer disease (Szabo, 1979). In fact, dopamine agonists may be antiulcerogenic drugs. A dopaminergic effect on electrolyte absorption has been demonstrated for the rabbit ileum. An additional effect of dopamine on GI function is its ability to increase blood flow through the arteries supplying most of the stomach and small intestine. Whether some or all of these GI effects of dopamine are physiologically relevant, especially in man, is still very much open to question. The presence of gut dopamine receptors appears to vary not only among species but among organs of the GI tract within one species. A thorough characterization of these receptors has not been performed. The evidence to date will be presented in the text of this chapter.

Keywords

Irritable Bowel Syndrome Dopamine Receptor Dopamine Agonist Lower Esophageal Sphincter Electrical Field Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman, D. M., and Woodward, P., 1983, Effect of SK&F 82526 on mesenteric blood flow (MBF) and resistance under normal and ischemic conditions in the dog, Fed. Proc. 42:748.Google Scholar
  2. Alander, T., Anden, N.-E., and Grabowska-Anden, M., 1980, Metoclopramide and sulpiride as selective blocking agents of pre-and postsynaptic dopamine receptors, Naunyn Schmiedebergs Arch. Pharmacol. 312:145–150.PubMedCrossRefGoogle Scholar
  3. Anuras, S., 1981, Effect of dopamine on opossum duodenal smooth muscle, Gastroenterology 80:51–54.PubMedGoogle Scholar
  4. Baeyens, R., Van de Velde, E., DeSchepper, A., Wollaert, F., and Reyntjens, A., 1979, Effects of intravenous and oral domperidone on the motor function of the stomach and small intestine, Postgrad. Med. J. 55(Suppl. 1): 19–23.PubMedGoogle Scholar
  5. Bastie, M. J., Vaysse, N., Brenac, B., Pascal, J. P., and Ribet, A., 1977, Effects of catecholamines and their inhibitors on the isolated canine pancreas. II. Dopamine, Gastroenterology 72:719–723.PubMedGoogle Scholar
  6. Bech, K., and Hovendal, C. P., 1982, Effect of dopamine on bethanechol-stimulated gastric antral motility in dogs with gastric fistula, Scand. J. Gastroenterol. 17:945–951.PubMedCrossRefGoogle Scholar
  7. Behar, J., and Biancani, P., 1976, Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state, Gastroenterology 70:331–335.PubMedGoogle Scholar
  8. Brock-Utne, J. G., 1980, Domperidone antagonizes the relaxant effect of atropine on the lower esophageal sphincter, Anesth. Anaig. Cleve. 59:921–924.Google Scholar
  9. Brogden, R. N., Carmine, A. A., Heel, R. C., Speight, T. M., and Avery, G. S., 1982, Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic, Drugs 24:360–400.PubMedCrossRefGoogle Scholar
  10. Bron, B., and Massih. L., 1980, Domperidone: A drug with powerful action on the lower esophageal sphincter pressure, Digestion 20:375–378.PubMedCrossRefGoogle Scholar
  11. Caldara, R., Ferrari. C, Romussi, M., Bierti, L., Gandini, S., and Curtarelli, G., 1978, Effect of dopamine infusion on gastric and pancreatic secretion and on gastrin release in man, Gut 19:724–728.PubMedCrossRefGoogle Scholar
  12. Cheng, H. C, and Long, J. P., 1974, Dopaminergic nature of apomorphine-induced pecking in pigeons, Eur. J. Pharmacol. 26:313–320.PubMedCrossRefGoogle Scholar
  13. Chey, W. Y., You, C. H., and Ange, D. A., 1982, Open and double blind clinical trials of domperidone in patients with unexplained nausea, vomiting, abdominal bloating and early satiety, Gastroenterology 82:1033.Google Scholar
  14. Costall, B., and Naylor, R. J., 1981, The hypotheses of different dopamine receptor mechanisms, Life Sci. 28:215–229.PubMedCrossRefGoogle Scholar
  15. Cox, B., and Ennis, C, 1980, Mechanism of action of dopamine on the guinea pig gastrooesophageal junction in vitro, Br. J. Pharmacol. 71:177–184.PubMedGoogle Scholar
  16. DeCarle, D. J., and Christensen, J., 1976, A dopamine receptor in esophageal smooth muscle of the opossum, Gastroenterology 70:216–219.Google Scholar
  17. Delcenserie, R., and Laugier, R., 1982, Dopamine effect on electrophysiology and amylase secretion from mouse pancreas, Digestion 25:24.Google Scholar
  18. Delcenserie, R., Devaux, M. A., and Sarles, H., 1982, Action of dopamine and domperidone on the basal meal stimulated secretion of bicarbonate and protein in the dog, Digestion 25:23.Google Scholar
  19. DeLoore, I., Van Ravensteyn, H., and Ameryckx, L., 1979, Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide, Postgrad. Med. J. 55(Suppl. 1):40–42.Google Scholar
  20. Donowitz, M., Cusolito, S., Battisti, L., Fogel, R., and Sharp, G. W. G., 1982, Dopamine Stimulation of active Na and C1 absorption in rabbit ileum. Interactions with α2-adrenergic and specific dopamine receptors, J. Clin. Invest. 69:1008–1016.PubMedCrossRefGoogle Scholar
  21. Dubois, A., Jacobus, J., Grissom, M., Eng, R., and Corral, M., 1981, Preventionof radiation induced vomiting and altered gastric emptying, Clin. Res. 29:712A. ai]Ehrlein, H.-J., 1981, Inhibition of reverse peristalsis of the intestine by domperidone, Scand. J. Gastroenterol. 16(Suppl. 67): 199–200.Google Scholar
  22. Ennis, C, Janssen, P. A. J., Schneiden, H. J., and Cox, B., 1979, Characterization of receptors on postganglionic cholinergic neurons in the guinea pig isolated ileum, J. Pharm. Pharmacol. 31:217–221.PubMedCrossRefGoogle Scholar
  23. Eyre-Brook, I. A., Linhardt, G. E., and Johnson, A. G., 1982, The effects of domperidone on antroduodenal motor activity in man: A double-blind study with a new technique. Br. J. Surg. 69:291.CrossRefGoogle Scholar
  24. Field, M., and McColl, I., 1973, Ion transport in rabbit ileal mucosa. III. Effects of catecholamines, Am. J. Physiol. 225:852–857.PubMedGoogle Scholar
  25. Fielding, J. F., 1982, Domperidone treatment in the irritable bowel syndrome, Digestion 23:125–127.PubMedCrossRefGoogle Scholar
  26. Fontaine, J., and Reuse, J., 1978, Pharmacological analysis of the effects of substituted benzamides on the guinea pig ileum. Study of metoclopramide, sulpiride, bromopride, tiapride and sultopride, Arch. Int. Pharmacodyn. Ther. 235:51–61.PubMedGoogle Scholar
  27. Fontaine, J., and Reuse, J., 1979, Pharmacological analysis of the effects of metoclopramide on the transmurally stimulated guinea pig ileum, Arch. Int. Pharmacodyn. Ther. 242:149–158.PubMedGoogle Scholar
  28. Fozard, J. R., and Mobarok Ali, A. T. M., 1978, Blockade of neuronal tryptamine receptors by metoclopramide, Eur. J. Pharmacol. 49:109–112.PubMedCrossRefGoogle Scholar
  29. Goldberg, L. I., and Kohli, J. D., 1983, Differentiation of dopamine receptors in the periphery, in: Dopamine Receptors (C. Kaiser and J. W. Kebabian, eds.), American Chemical Society Publications, Washington ACS Symposium Series 224, pp. 101–113.CrossRefGoogle Scholar
  30. Goldberg, L. I., Volkman, P. H., and Kohli, J. D., 1978, A comparison of the vascular dopamine receptor with other dopamine receptors, Annu. Rev. Pharmacol. Toxicol. 18:57–79.PubMedCrossRefGoogle Scholar
  31. Gorich, R., Weihrauch, T. R., and Kilbinger, H., 1982, The inhibition by dopamine of cholinergic transmission in the isolated guinea pig ileum, Naunyn Schmiedebergs Arch. Pharmacol. 318:308–312.PubMedCrossRefGoogle Scholar
  32. Hay, A. M., and Man, W. K., 1979, Effect of metoclopramide on guinea pig stomach. Critical dependence on intrinsic Stores of acetylcholine, Gastroenterology 76:492–496.PubMedGoogle Scholar
  33. Hoffbrand, B. I. (ed.), 1979, Domperidone in the Treatment of Upper Gastro-Intestinal Symptoms, Postgraduate Medical Journal, Volume 55, Supplement 1, Fellowship of Postgraduate Medicine, London, Blackwell Scientific Publications, Oxford.Google Scholar
  34. Holzbauer, M., and Sharman, D. F., 1972, The distribution of catecholamines in vertebrates, in: Handbook of Experimental Pharmacology, Volume 33 (H. Blaschko and E. Muscholl, eds.), Springer-Verlag, New York, pp. 110–185.Google Scholar
  35. Horner, H. C, and Szabo, S., 1981, Differential effect of changing central and peripheral catecholamine levels in cysteamine-induced duodenal ulcer in the rat, Life Sci. 29:2437–2443.PubMedCrossRefGoogle Scholar
  36. Jacobson, E. D., 1982, Physiology of the mesenteric circulation, Physiologist 25:439–443.PubMedGoogle Scholar
  37. Jacoby, H. I., and Brodie, D. A., 1967, Gastrointestinal actions of metoclopramide: An experimental study, Gastroenterology 52:676–684.PubMedGoogle Scholar
  38. Johnson, A. G., 1971, The effect of metoclopramide on gastroduodenal and gallbladder contractions, Gut 12:158–163.PubMedCrossRefGoogle Scholar
  39. Kahn, T., Elias, E. G., and Mason, G. R., 1978, A single dose of metoclopramide in the control of vomiting from c/s-dichlorodiammineplatinum (II) in man, Cancer Treat. Rep. 62:1106–1107.PubMedGoogle Scholar
  40. Kauffman, G. L., Jr., 1982, Blood flow and gastric secretion, Fed. Proc. 41:2080–2083.PubMedGoogle Scholar
  41. Kebabian, J. W., and Calne, D. B., 1979, Multiple receptors for dopamine, Nature 277:93–96.PubMedCrossRefGoogle Scholar
  42. Kilbinger, H., and Weihrauch, T. R., 1982, Drugs increasing gastrointestinal motility, Pharmacology 25:61–72.PubMedCrossRefGoogle Scholar
  43. Kilbinger, H., Kruel, R., Pfeuffer-Friederich, I., and Wessler, I., 1982, The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea pig ileum, Naunyn Schmiedebergs Arch. Pharmacol. 319:231–238.PubMedCrossRefGoogle Scholar
  44. Lanciault, G., and Jacobson, E. D., 1976, The gastrointestinal circulation, Gastroenterology 71:851–873.PubMedGoogle Scholar
  45. Lanfranchi, G. A., Marzio, L., Cortini, C, and Osset, E. M., 1978a, Motor effect of dopamine on human sigmoid colon. Evidence for specific receptors, Am. J. Dig. Dis. 23:257–263.CrossRefGoogle Scholar
  46. Lanfranchi, G. A., Marzio, L., Cortini, C, Trento, L., and Labo, G., 1978b, Effect of dopamine on gastric motility in man: Evidence for specific receptors, in: Gastrointestinal Motility in Health and Disease (H. L. Duthie, ed.), MTP Press, Lancaster, pp. 161–172.Google Scholar
  47. Lechin, F., and Van Der Dijs, B., 1979, Effects of dopaminergic blocking agents on distal colon motility, J. Clin. Pharmacol. 19:617–625.PubMedGoogle Scholar
  48. Lux, G., Engel, H., and Rosch, W., 1981, The stimulation of oesophageal motility with bromopride, domperidone, and metoclopramide, in: Progress with Domperidone, A Gastrokinetic and Anti-emetic Agent, Royal Society of Medicine International Congress and Symposium Series, No. 36, The Royal Society of Medicine Academic Press, London, pp. 29–36.Google Scholar
  49. Malagelada, J.-R., 1982, Gastric emptying disorders. Clinical significance and treatment, Drugs 24:353–359.PubMedCrossRefGoogle Scholar
  50. Masso, J. L., and Roberts, D. J., 1980, Comparison of the potencies of clebopride and other substituted benzamide drugs on isolated gastrointestinal tract of the guinea pig and rat, J. Pharm. Pharmacol. 32:727–728.PubMedCrossRefGoogle Scholar
  51. Milo, R., 1980, Use of the peripheral dopamine antagonist, domperidone, in the management of gastrointestinal Symptoms in patients with irritable bowel syndrome, Curr. Med. Res. Opin. 6:577–584.PubMedCrossRefGoogle Scholar
  52. Mukhopadhyay, A. K., and Weisbrodt, N., 1977, Effect of dopamine on esophageal motor function, Am. J. Physiol. 232:E19–E24.PubMedGoogle Scholar
  53. Niemegeers, C. J. E., and Janssen, P. A. J., 1979, A systematic study of the pharmacological activities of dopamine antagonists, Life Sci. 24:2201–2216.PubMedCrossRefGoogle Scholar
  54. O’Connor, S. E., and Brown, R. A., 1982, The pharmacology of sulpiride—a dopamine receptor antagonist, Gen. Pharmacol. 13:185–193.PubMedCrossRefGoogle Scholar
  55. Ormsbee, H. S. III, and Bass, P., 1976, Gastroduodenal motor gradients in the dog after pyloroplasty, Am. J. Physiol. 230:389–397.PubMedGoogle Scholar
  56. Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M., and Avery, G. S., 1976, Metoclopramide: A review of its pharmacological properties and clinical use, Drugs 12:81–131.PubMedCrossRefGoogle Scholar
  57. Pozzessere, C., Materia, E., Corazziari, E., and Anzini, F., 1982, Effects of domperidone on oesophageal motor activity and gastro-oesophageal reflux, Ital. J. Gastroenterol. 14:159–161.Google Scholar
  58. Rattan, S., and Goyal, R. K., 1976, Effect of dopamine on the esophageal smooth muscle in vivo, Gastroenterology 70:377–381.PubMedGoogle Scholar
  59. Reinsberg, J., and Kullmann, R., 1982, The gastric circulation of the rabbit: A model for the in vivo characterization of the dopamine vascular receptor, Naunyn Schmiedebergs Arch. Pharmacol. 321:R63.CrossRefGoogle Scholar
  60. Richter, J. E., and Castell, D. O., 1982, Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy, Ann. Intern. Med. 97:93–103.PubMedGoogle Scholar
  61. Roberts, D. J., 1982, The pharmacological basis of the therapeutic activity of clebopride and related substituted benzamides, Curr. Ther. Res. 31:(1S):S1–S44.Google Scholar
  62. Sandrock, A. W., 1981, Identification and binding properties of dopamine receptors in the rat gut: Possible role in experimental duodenal ulcerogenesis, Gastroenterology 80:1362.Google Scholar
  63. Satoh, Y., Satoh, H., and Honda, F., 1980, Dopamine receptor blocking activity of Sulpiride in the canine exocrine pancreas, Jpn. J. Pharmacol. 30:689–699.PubMedCrossRefGoogle Scholar
  64. Schrumpf, E., and Linnestad, P., 1982, Effect of cholinergic, adrenergic, and dopaminergic blockade on gastrin secretion in healthy subjects, Scand. J. Gastroenterol. 17:29–31.PubMedCrossRefGoogle Scholar
  65. Schulze-Delrieu, K., 1979, Metoclopramide, Gastroenterology 77:768–779.PubMedGoogle Scholar
  66. Schulze-Delrieu, K., 1981, Metoclopramide, N. Engl. J. Med. 305:28–33.PubMedCrossRefGoogle Scholar
  67. Schuurkes, J. A. J., and Van Nueten, J. M., 1981a, Effects of dopamine and its antagonist domperidone cannot be explained by an effect on α1-adrenergic receptors, Arch. Int. Pharmacodyn. Ther. 250:324–327.Google Scholar
  68. Schuurkes, J. A. J., and Van Nueten, J. M., 1981b, Is dopamine an inhibitory modulator of gastrointestinal motility? Scand. J. Gastroenterol. 16(Suppl. 67):33–36.Google Scholar
  69. Schuurkes, J. A. J., and Van Nueten, J. M., 1982, Dose-dependent Stimulation of antroduodenal coordination by domperidone via specific dopamine-receptors, Arch. Int. Pharmacodyn. Ther. 256:311–314.PubMedGoogle Scholar
  70. Snape, W. J., Jr., Battie, W. M., Schwartz, S. S., Braunstein, S. N., Goldstein, H. A., and Alavi, A., 1982, Metoclopramide to treat gastroparesis due to diabetes mellitus: A double-blind, controlled trial, Ann. Intern. Med. 96:444–446.PubMedGoogle Scholar
  71. Sowers, J. R., Stern, N., and Taylor, I. L., 1982, Evidence for dopaminergic modulation of pancreatic Polypeptide secretion in man, Life Sci. 31:2971–2975.PubMedCrossRefGoogle Scholar
  72. Stadaas, J. O., and Aune, S., 1972, The effect of sulpiride on gastric motility, Scand. J. Gastroenterol. 7:717–721.PubMedCrossRefGoogle Scholar
  73. Szabo, S., 1978, Animal model: Cysteamine-induced acute and chronic duodenal ulcer in the rat, Am. J. Pathol. 93:273–276.PubMedGoogle Scholar
  74. Szabo, S., 1979, Dopamine disorder in duodenal ulceration, Lancet 2:880–882.PubMedCrossRefGoogle Scholar
  75. Szabo, S., and Neumeyer, J. L., 1983, Dopamine agonists and antagonists in duodenal ulcer disease, in: Dopamine Receptors (C. Kaiser and J. W. Kebabian, eds.), ACS Symposium Series 224 American Chemical Society Publications, Washington, pp. 175–176.CrossRefGoogle Scholar
  76. Szabo, S., Reynolds, E. S., Lichtenberger, L. M., Haith, L. R., Jr., and Dzau, V. J., 1977, Pathogenesis of duodenal ulcer. Gastric hyperacidity caused by propionitrile and cysteamine in rats, Res. Commun. Chem. Pathol. Pharmacol. 16:311–323.PubMedGoogle Scholar
  77. Szabo, S., Haith, L. R., Jr., and Reynolds, E. S., 1979, Pathogenesis of duodenal ulceration produced by cysteamine or propionitrile. Influence of vagotomy, sympathectomy, histamine depletion, H-2 receptor antagonists and hormones, Dig. Dis. Sci. 24:471–477.PubMedCrossRefGoogle Scholar
  78. Telford, G. L., Ormsbee, H. S. III, Eisenstat, T. E., and Mason, G. R., 1978, Effect of metoclopramide on delayed gastric emptying and disorders of esophageal motility, Curr. Surg. 35:438–441.Google Scholar
  79. Thompson, B. K., and de Carle, D. J., 1982, The effect of dopamine on human gastric smooth muscle, Aust. J. Exp. Biol. Med. Sci. 60:123–127.PubMedCrossRefGoogle Scholar
  80. Thorner, M. O., 1975, Dopamine is an important neurotransmitter in the autonomic nervous system, Lancet 1:662–665.PubMedCrossRefGoogle Scholar
  81. Towse, G. (ed.), 1981, Progress With Domperidone, A Gastrokinetic and Anti-emetic Agent, Royal Society of Medicine International Congress and Symposium Series, No. 36, The Royal Society of Medicine/Academic Press, London, Grune & Stratton, New York.Google Scholar
  82. Uvnas-Wallensten, K., Lundberg, J. M., and Efendic, S., 1978, Dopaminergic control of antral gastrin and somatostatin release, Acta Physiol. Scand. 103:343–345.PubMedCrossRefGoogle Scholar
  83. Valenzuela, J. E., 1976, Dopamine as a possible neurotransmitter in gastric relaxation, Gastroenterology 71:1019–1022.PubMedGoogle Scholar
  84. Valenzuela, J. E., 1981, Effects of domperidone on the symptoms of reflux oesophagitis, in: Progress With Domperidone, A Gastrokinetic and Anti-emetic Agent, Royal Society of Medicine International Congress and Symposium Series, No. 36, The Royal Society of Medicine/Academic Press, London, pp. 51–56.Google Scholar
  85. Valenzuela, J. E., Defilippi, C, Diaz, G., Navia, E., and Merino, Y., 1979, Effect of dopamine on human gastric and pancreatic secretion, Gastroenterology 76:323–326.PubMedGoogle Scholar
  86. Van Nueten, J. M., and Janssen, P. A., 1978, Is dopamine an endogenous inhibitor of gastric emptying? in: Gastrointestinal Motility in Health and Disease, (H. L. Duthie, ed.), MTP Press, Lancaster, pp. 173–181.Google Scholar
  87. Van Nueten, J. M., Ennis, C, Helsen, L., Laduron, P. M., and Janssen, P. A. J., 1978, Inhibition of dopamine receptors in the stomach: An explanation of the gastrokinetic properties of domperidone, Life Sciences 23:453–458.PubMedCrossRefGoogle Scholar
  88. Wauquier, A., Niemegeers, C. J. E., and Janssen, P. A. J., 1981, Neuropharmacological comparison between domperidone and metoclopramide, Jpn. J. Pharmacol. 31:305–314.PubMedCrossRefGoogle Scholar
  89. Weihrauch, T. R., and Ehl, W., 1981, Effect of domperidone on the motility of the antrum, pylorus and duodenum in man, Scand. J. Gastroenterol. 16(Suppl. 67): 195–198.Google Scholar
  90. Weihrauch, T. R., Forster, C. F., and Krieglstein, J., 1979, Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry, Postgrad. Med. J. 55(Suppl. 1):7–10.PubMedGoogle Scholar
  91. Yeh, B. K., McNay, J. L., and Goldberg, L. I., 1969, Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: Evidence for a specific dopamine receptor, J. Pharmacol. Exp. Ther. 168:303–309.PubMedGoogle Scholar
  92. Zar, M. A., Ebong, O. O., and Bateman, D. N., 1982, Effect of metoclopramide in guinea pig ileum longitudinal muscle: Evidence against dopamine-mediation, Gut 23:66–70.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Herbert S. OrmsbeeIII
    • 1
  1. 1.Department of PharmacologySmith Kline & French LaboratoriesPhiladelphiaUSA

Personalised recommendations